The CDC has the final say on who qualifies for the COVID-19 booster shot and began deliberations on Wednesday by convening its own advisor.
Washington- Influential Advisory Board to Centers for Disease Control and Prevention Convened on Wednesday to discuss which Americans should get the COVID-19 booster shot when. This is a more controversial question than the Biden administration had clearly expected.
meeting Came a few days later Another advisory group — It serves the Food and Drug Administration — overwhelmingly rejected the White House’s large-scale plan to distribute third shots to almost everyone. Instead, the panel approved a booster dose of Pfizer vaccine only for the elderly and those at high risk for the virus.
COVID-19 vaccination It continues to provide strong protection against severe illness, hospitalization and death, and immunity to mild infections appears to be diminished months after vaccination.
Last week’s FDA Advisory Board decision was only the first hurdle when the government set up a booster policy. The FDA itself must decide whether to agree with the advisor’s recommendations and approve the Pfizer booster.
If so, the CDC must recommend who should take additional shots after hearing from the Immunization Implementation Advisory Board, where the meeting was scheduled to be extended on Thursday.
The priority remains unvaccinated, and the CDC states that it accounts for the majority of COVID-19 cases and has skyrocketed to levels not seen since last winter. About 182 million Americans are fully vaccinated, accounting for nearly 55% of the total population.
Dr. Matthew Daly, a researcher at Kaiser Permanente, Colorado, said: CDC advisor who held a meeting on Wednesday.
Much of the discussion at the meeting was expected to be about who is considered to be at high enough risk for additional doses. For example, whether health care workers who are continuously exposed to the virus need to qualify for booster immunization.
Another question was whether to give a booster months after the second shot. Scientists talked for about 6 or 8 months.
Many experts are worried about the need for boosters because they believe the COVID-19 vaccine is working as expected. It is normal for antibodies that fight the virus to decline months after vaccination. Still, the body has backup protection against viruses.
Part of the government’s calculations is that preventing fully vaccinated “breakthrough” infections will reduce viral infections, protect infants who are not yet vaccinated, and burden the overwhelming medical system. Whether it helps to mitigate.
The government will later decide whether to allow additional doses of Moderna or Johnson & Johnson vaccines.
The Associated Press’s Department of Health Sciences is supported by the Department of Science Education at the Howard Hughes Medical Institute. AP is solely responsible for all content.
The Covid Booster Shot Pfizer discussion will move to the CDC panel on Wednesday
Source link The Covid Booster Shot Pfizer discussion will move to the CDC panel on Wednesday